David Zidar, MD
Cardiovascular Disease · Euclid, OHNPI 1972571651
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 58.0% of the total. Reporting peaked in 2019 at $8,098 and has fallen 96.0% since, to $328 in 2025.
Across 49 payments — averaging $297.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- E.r. Squibb & Sons, L.L.C.$6K
- Shockwave Medical, Inc$129
- W. L. Gore & Associates, Inc.$95
- Boston Scientific$82
- Terumo Medical Corporation$63
- plus $113 from 4 others
Across 24 payments — averaging $7029.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$133K
- Abbott$36K
What the payments were for
- Consulting fees$4,22529%
- Speaking & faculty fees$6,88147%
- Travel & lodging$1,1918%
- Food & beverage$2,14515%
- Education$1341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 27 | $8,449 |
| E.r. Squibb & Sons, L.L.C. | 7 | $5,645 |
| Shockwave Medical, Inc | 3 | $129 |
| W. L. Gore & Associates, Inc. | 1 | $95 |
| Boston Scientific | 1 | $82 |
| Terumo Medical Corporation | 1 | $63 |
| Johnson & Johnson | 4 | $54 |
| Philips North America LLC | 3 | $41 |
| Boehringer Ingelheim | 1 | $16 |
| Cvrx, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$5,521
- RESOLUTE ONYX$3,500
- Resolute$2,108
- ONYX FRONTIER$1,918
- HawkOne$146
- Octopus$145
- Vascular Lithotripsy$119
- SYMPLICITY G3$114
How this compares
$14,576 in reported general payments places this provider in the 85th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Euclid
- Guilherme AttizzaniCleveland$1.3M
- Gregory LamCircleville$428K
- Emil HayekHudson$379K
- Abraham LincoffCleveland$369K
- Oussama WazniCleveland$367K
- Ian NeelandCleveland$329K
- Kamal ShemisaCincinnati$314K
- Mehdi ShishehborElyria$237K
- Abdu HawwaGarfield Hts$234K
- Jayanta MukherjeeColumbus$227K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.